Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126797441 | 12679744 | 1 | I | 20080310 | 0 | 20160823 | 20160823 | DIR | 27.00 | YR | F | N | 170.00000 | LBS | 20160822 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126797441 | 12679744 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | N | D | 0 | BID | ||||||||
| 126797441 | 12679744 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Y | D | 0 | ||||||||||
| 126797441 | 12679744 | 4 | C | LOOP RECORDER (HEART MONITOR) | 2 | 0 | |||||||||||||
| 126797441 | 12679744 | 6 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 10 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 12 | C | MECLAZINE | 2 | 0 | |||||||||||||
| 126797441 | 12679744 | 14 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 16 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 18 | C | ALPHA LIPOIC ACID | .ALPHA.-LIPOIC ACID | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 20 | C | B VITAMIN COMPLEX | 2 | 0 | |||||||||||||
| 126797441 | 12679744 | 22 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 24 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 126797441 | 12679744 | 26 | C | METOPROLOL. | METOPROLOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126797441 | 12679744 | 1 | Bronchitis |
| 126797441 | 12679744 | 1 | Sinusitis |
| 126797441 | 12679744 | 2 | Bronchitis |
| 126797441 | 12679744 | 2 | Sinusitis |
| 126797441 | 12679744 | 2 | Tooth disorder |
| 126797441 | 12679744 | 2 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126797441 | 12679744 | LT |
| 126797441 | 12679744 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126797441 | 12679744 | Abnormal loss of weight | |
| 126797441 | 12679744 | Abnormal weight gain | |
| 126797441 | 12679744 | Ataxia | |
| 126797441 | 12679744 | Cluster headache | |
| 126797441 | 12679744 | Dizziness | |
| 126797441 | 12679744 | Fatigue | |
| 126797441 | 12679744 | Feeling abnormal | |
| 126797441 | 12679744 | Hypertension | |
| 126797441 | 12679744 | Hypotension | |
| 126797441 | 12679744 | Hypothyroidism | |
| 126797441 | 12679744 | Influenza like illness | |
| 126797441 | 12679744 | Insomnia | |
| 126797441 | 12679744 | Memory impairment | |
| 126797441 | 12679744 | Muscle contractions involuntary | |
| 126797441 | 12679744 | Muscle spasms | |
| 126797441 | 12679744 | Muscular weakness | |
| 126797441 | 12679744 | Myalgia | |
| 126797441 | 12679744 | Neuropathy peripheral | |
| 126797441 | 12679744 | Scarlet fever | |
| 126797441 | 12679744 | Skin disorder | |
| 126797441 | 12679744 | Swelling | |
| 126797441 | 12679744 | Syncope | |
| 126797441 | 12679744 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126797441 | 12679744 | 1 | 20080310 | 0 |